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Inhibition of protein synthesis per se does not potentiate the stress-activated protein kinases (SAPKs; also
known as cJun NH2-terminal kinases [JNKs]). The protein synthesis inhibitor anisomycin, however, is a
potent activator of SAPKs/JNKs. The mechanism of this activation is unknown. We provide evidence that in
order to activate SAPK/JNK1, anisomycin requires ribosomes that are translationally active at the time of
contact with the drug, suggesting a ribosomal origin of the anisomycin-induced signaling to SAPK/JNK1. In
support of this notion, we have found that aminohexose pyrimidine nucleoside antibiotics, which bind to the
same region in the 28S rRNA that is the target site for anisomycin, are also potent activators of SAPK/JNK1.
Binding of an antibiotic to the 28S rRNA interferes with the functioning of the molecule by altering the
structural interactions of critical regions. We hypothesized, therefore, that such alterations in the 28S rRNA
may act as recognition signals to activate SAPK/JNK1. To test this hypothesis, we made use of two ribotoxic
enzymes, ricin A chain and a-sarcin, both of which catalyze sequence-specific RNA damage in the 28S rRNA.
Consistent with our hypothesis, ricin A chain and a-sarcin were strong agonists of SAPK/JNK1 and of its
activator SEK1/MKK4 and induced the expression of the immediate-early genes c-fos and c-jun. As in the case
of anisomycin, ribosomes that were active at the time of exposure to ricin A chain or a-sarcin were able to
initiate signal transduction from the damaged 28S rRNA to SAPK/JNK1 while inactive ribosomes were not.
The activity of the stress-activated protein kinases (SAPKs;
also known as cJun NH2-terminal kinases [JNKs]) is stimulated
in response to certain kinds of cellular stress, including expo-
sure of cells to short-wavelength UV radiation (11, 19), alky-
lating DNA-damaging agents (27), the tumor promoters As31
(7) and palytoxin (23), hyperosmotic shock (16), proinflamma-
tory cytokines (24), or withdrawal of a trophic factor (54).
SAPKs/JNKs are members of the mitogen-activated protein
kinase (MAPK) family of proline-directed serine/threonine
protein kinases, which also includes the extracellular signal-
regulated kinases (ERKs) and the p38/RK/HOG1 kinase
(for a review, see reference 51). Upon activation, SAPKs/
JNKs phosphorylate and activate transcription factors such
as cJun (11), ATF-2 (17, 49), and Elk-1 (6, 52, 56), leading
ultimately to the transcriptional activation of the immedi-
ate-early genes c-fos and c-jun (49, 56). The signal transduc-
tion cascades that lead to activation of SAPKs/JNKs and to
subsequent gene induction are thought to be associated with
stress responses that promote either cell recovery and sur-
vival after cellular damage (13, 18, 41) or, in some instances,
apoptotic death (8, 54). The activity of SAPKs/JNKs is reg-
ulated through their phosphorylation on both threonine and
tyrosine residues in the motif TpPYp by the dual-specificity
protein kinase SEK1/MKK4 (12, 26, 40). The protein kinase
MEKK1 (25), in turn, activates SEK1/MKK4 through phos-
phorylation of serine 219 and threonine 223 (55). The mode
of regulation of MEKK1 (and of other potential SEK1/
MKK4 kinases) by cellular stress remains unclear, but it is
thought that the SEK1/MKK4-SAPK/JNK cascade is con-
trolled through activation of small GTP-binding proteins,
including Ras (11), Cdc42, Rac1 (9), and Rho (47). The set
of GTPases that regulate SAPKs/JNKs seems to be cell type
specific (47).
The antibiotic anisomycin inhibits the eukaryotic peptidyl
transferase reaction (36, 50) and is a potent agonist of SAPKs/
JNKs (56) and other cellular protein kinases, such as
MAPKAP-2 (3). Efficient kinase activation was achieved with
concentrations of anisomycin that inhibited protein synthesis
by less than 50% (4, 56); it was therefore concluded that
anisomycin activates protein kinases independently of its abil-
ity to inhibit protein synthesis (4). Here, we provide evidence
that ribosomes that are functional at the time of contact with
anisomycin are involved in the anisomycin-induced signal
transduction to SAPK/JNK1. The binding site for anisomycin
in the ribosome is located in the 28S rRNA (21, 39, 45) in a
region that has been suggested to be part of the peptidyl
transferase center (2, 39). It was our hypothesis, therefore, that
the 28S rRNA may play a crucial role in initiating signal trans-
duction from the ribosome to SAPK/JNK1. To directly test this
hypothesis, we took advantage of the fact that two ribotoxic
enzymes, ricin A chain and a-sarcin, catalyze highly specific
RNA damage within a conserved loop, the a-sarcin/ricin (S/R)
loop, of the 28S rRNA (53). We asked whether ricin A chain
and a-sarcin could activate SAPK/JNK1 and its activator,
SEK1/MKK4, and found that this was indeed the case. Like
anisomycin, ricin A chain and a-sarcin required the presence
of actively translating ribosomes in order to activate SEK1/
MKK4 and SAPK/JNK1.













Cell culture. Rat-1 cells were maintained as previously described (28). All
experiments presented here were performed with confluent, quiescent cultures
obtained through serum deprivation for typically 48 h.
Chemicals and ribotoxins. Anisomycin, puromycin, cycloheximide, emetine,
T-2 toxin, gougerotin, RCA60, a-sarcin, Pseudomonas exotoxin A, and diphtheria
toxin were from Sigma Chemical Company, St. Louis, Mo. Pactamycin was a
generous gift from the Upjohn Company, Kalamazoo, Mich. Blasticidin S was
from Calbiochem, San Diego, Calif. Before use, puromycin, cycloheximide, and
blasticidin S were dissolved freshly in double-distilled H2O. Anisomycin, eme-
tine, pactamycin, T-2 toxin, and gougerotin were dissolved in (H3C)2SO. a-Sar-
cin, Pseudomonas exotoxin A, and diphtheria toxin were reconstituted in double-
distilled H2O at 1 mg/ml in accordance with the manufacturer’s instructions. In
all the cases in which (H3C)2SO was used as a vehicle, corresponding control
cells received the same amount of the vehicle alone (typically not more than
0.2% [vol/vol]). All radiochemicals were from DuPont NEN Research Products,
Boston, Mass.
SAPK/JNK1 immunoprecipitation and immunocomplex kinase assay. Rat-1
cells from a 6-cm-diameter tissue culture dishes were harvested by lysis in a
solution containing 20 mM HEPES-KOH (pH 7.4), 2 mM EGTA, 50 mM
b-glycerophosphate, 1 mM dithiothreitol (DTT), 10% glycerol, 1% Triton
X-100, 1 mM sodium vanadate, 1 mM microcystin, 1 mM phenylmethylsulfonyl
fluoride, 1 mg of aprotinin per ml, and 1 mg of leupeptin per ml. SAPK/JNK1 was
immunoprecipitated for 3 h at 4°C with an anti-JNK1 antibody (sc-474; Santa
Cruz Biotechnology Inc., Santa Cruz, Calif.) precoupled to protein A-agarose
(Santa Cruz Biotechnology). The immunoprecipitates were washed once with
lysis buffer, once with a solution consisting of 100 mM Tris-HCl (pH 7.6), 500
mM LiCl, 1 mM DTT, and 0.1% Triton X-100, and once with a buffer containing
20 mM morpholinepropanesulfonic acid (MOPS; pH 7.2), 10 mM MgCl2, 2 mM
EGTA, 1 mM DTT, and 0.1% Triton X-100. For the kinase reaction, the
immunoprecipitates were incubated with 1 mg of either glutathione S-transferase
(GST)-Elk1 (38) or GST-cJun (24) fusion proteins in the presence of 10 mM
MOPS (pH 7.2), 20 mM MgCl2, 1 mM EGTA, 0.5 mM DTT, 0.05% Triton
X-100 and 1 mCi [g-32P]ATP for 20 min at 30°C. After the reactions were
stopped by adding 10 ml of 43 sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) loading buffer, the samples were resolved by SDS–13%
PAGE. The phosphorylated GST-Elk1 was quantified from dried gels with a
Molecular Dynamics PhosphorImager and IP Lab Gel software.
Western blot analysis of SEK1/MKK4. Rat-1 cells from a 10-cm-diameter
tissue culture plate were lysed in 500 ml of boiling 23 SDS-PAGE loading buffer.
The lysates were sheared by passing them five times through a 27-gauge needle,
separated via SDS–13% PAGE, and transferred onto a polyvinylidene difluoride
membrane (Millipore, Bedford, Mass.). The activation of SEK1/MKK4 was
demonstrated in a Western blot with an antibody directed against the SEK1/
MKK4 protein phosphorylated at Thr-223 (no. 9151S; New England BioLabs
Inc., Beverly, Mass.) in accordance with the manufacturer’s instructions.
Northern blot analysis of RNA. Rat-1 cells were harvested from two 10-cm-
diameter tissue culture dishes per experimental point, and total cellular RNA
was extracted, separated by electrophoresis, and analyzed by the Northern blot-
ting procedure as previously described (28). The hybridization probes for c-fos,
c-jun, and cyclophilin are described elsewhere (37).
Measurement of protein synthesis via [3H]leucine incorporation. Rat-1 cells,
grown in 12-well tissue culture plates, were leucine deprived by placing them in
1 ml of Dulbecco modified Eagle medium lacking leucine (DMEM/2Leu) for 1 h
before treatment with different inhibitors of translation. At various times (as
indicated in the text and in the figure legends), the cells were pulse-labeled for
5 min with 2 mCi of [3H]leucine in 50 ml of DMEM/2Leu. The incorporation of
[3H]leucine was stopped by adding 1 ml of 10% trichloroacetic acid (TCA). After
the cells were washed four times with 5% TCA, the TCA-insoluble proteins were
solubilized in 250 ml of 88% HCOOH. A 200-ml aliquot of each specimen was
transferred into a scintillation vial, 4 ml of aqueous scintillation liquid was added
to each vial, and the samples were counted in a scintillation counter. In each
experiment, three wells were used per experimental point.
Delivery of a-sarcin, diphtheria toxin, gougerotin, and blasticidin S into Rat-1
cells via lipofection. Lipofection was performed in 6-cm-diameter tissue culture
dishes whenever SAPK/JNK1 activity was assayed (2 ml of lipofection mix) and
in 12-well tissue culture plates whenever [3H]leucine incorporation was mea-
sured (480 ml of lipofection mix). The following protocol was used for prepara-
tion of 480 ml of lipofection mix: 6 ml of Lipofectin Reagent (Gibco BRL/Life
Technologies, Gaithersburg, Md.) was gently mixed with 104 ml of DMEM
(serum and antibiotic free) in polystyrene tubes. Ten microliters of a-sarcin (1
mg/ml) or diphtheria toxin (1 mg/ml) or five microliters of gougerotin (30 mM)
or blasticidin S (30 mM) was added, and after gentle mixing, the protein-lipid
vesicles were allowed to form for 10 min at room temperature. The mixture was
diluted with 360 ml (365 ml in the case of antibiotics) DMEM (serum and
antibiotic free) and applied onto cells from which the old medium had been
removed completely. Control cells were treated the same way except that the
toxins and antibiotics were omitted from the lipofection mix. For the lipofection
of cells in 6-cm-diameter dishes, the lipofection mix was scaled up to a final
volume of 2 ml.
Reverse transcription of rRNA by primer extension. Reverse transcription of
rRNA was performed as described in reference 20, with modifications. Crude
oligonucleotide primer (59-CACATACACCAAATGTC-39; Genosys Biotech-
nologies, Inc., The Woodlands, Tex.) was end labeled with T4 polynucleotide
kinase (Gibco BRL/Life Technologies) and then purified electrophoretically by
using the Full-Lengther apparatus (BioKey/Cascade Biologics, Portland, Oreg.).
For primer extension, a 10-ml mixture of 2 mg of total RNA plus 0.5 to 1.0 pmol
of primer in 50 mM Tris-HCl (pH 8.3)–75 mM KCl–3 mM MgCl2 was heated for
3 min at 90°C, placed on ice for 5 min, and then incubated at room temperature
for 5 min before initiation of reverse transcription by addition of 10 ml of a
mixture containing 2 mM deoxynucleoside triphosphates (dNTPs) and 30 U of
reverse transcriptase (Superscript; Gibco BRL/Life Technologies) in 50 mM
Tris-HCl (pH 8.3)–75 mM KCl–3 mM MgCl2–10 mM DTT. Following 15 min of
incubation at 48°C, the reactions were stopped by adding EDTA to 5 mM.
Reaction products were precipitated in ethanol in the presence of 1 to 2 mg of
glycogen, resuspended in formamide gel loading buffer, heat denatured, and
electrophoresed in 8% acrylamide sequencing gels, which were subsequently
dried and exposed to film and/or a PhosphorImager screen. The sequence of the
primer-extended transcript was determined by carrying out 10-ml dideoxynucle-
otide sequencing reactions. rRNA and primer were annealed as indicated above
but in half the volume. Primer extension for 15 min at 48°C included 0.1 mM
dNTPs and either 0.5 mM ddGTP, 1.0 mM ddATP, 0.5 mM ddTTP, or 1.0 mM
ddCTP; this was followed by a 5-min chase with 1.0 mM dNTPs.
RESULTS
Uncoupling of anisomycin-induced protein synthesis inhibi-
tion and activation of SAPK/JNK1. In order to understand the
mechanism of the anisomycin-induced SAPK/JNK1 activation
in Rat-1 cells, we did studies to determine whether this acti-
vation correlates with the inhibition of protein synthesis. To
this end, two experimental approaches were chosen.
First, we treated Rat-1 cells with different concentrations of
anisomycin and monitored both the inhibition of protein syn-
thesis (as measured by incorporation of [3H]leucine) and the
degree of SAPK/JNK1 activation (Fig. 1). The activity of
SAPK/JNK1 was examined in immunocomplex kinase assays
using bacterially expressed GST-Elk1 (38) (Fig. 1; see also Fig.
2, 3b, 4b, 6, and 7) or GST-cJun (24) (see Fig. 3c) fusion
proteins as substrates for phosphorylation (see Materials
and Methods). Half-maximal activation of SAPK/JNK1 was
achieved at a concentration of anisomycin that inhibited less
than 10% of the protein synthesis (60 ng/ml [Fig. 1a]). Thus, in
Rat-1 cells, anisomycin was able to activate SAPK/JNK1 sig-
nificantly without severely affecting translation.
Second, we determined the extent to which inhibition of
protein synthesis per se affects the activity of SAPK/JNK1. To
this end, we treated Rat-1 cells with inhibitors of either trans-
lational initiation (pactamycin and T-2 toxin) or translational
elongation (anisomycin, cycloheximide, puromycin, and eme-
tine) and compared the abilities of these inhibitors to activate
SAPK/JNK1. The modes of action of these translational inhib-
itors are summarized in Fig. 2a. At concentrations sufficient to
inhibit [3H]leucine incorporation by more than 95% (Fig. 2b),
there was no correlation between the potentials of these agents
to inhibit protein synthesis and their potentials to activate
SAPK/JNK1. Of the ribosomal inhibitors tested, anisomycin
was the most potent in activating the kinase (typically more
than 20-fold activation [Fig. 2c]), and it was the only agent that
activated SAPK/JNK1 significantly within 15 min of addition
(.15-fold activation [Fig. 2c]). Cycloheximide, puromycin, and
T-2 toxin appeared to be weaker activators (between three-
and eightfold activation [Fig. 2c]). Most importantly, pactamy-
cin and emetine completely failed to activate SAPK/JNK1
(Fig. 2c).
Functional ribosomes are required for anisomycin-induced
activation of SAPK/JNK1. One possible explanation for the
foregoing results was that the activation of SAPK/JNK1 by
anisomycin is independent of the action of the drug on ribo-
somes. This question was addressed experimentally by deter-
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mining whether a prior inactivation of the ribosomal function
by another antibiotic (that does not activate SAPK/JNK1)
could diminish the response of the kinase to anisomycin. Two
distinct approaches were chosen for ribosomal inactivation: (i)
inhibition of translational initiation by pretreatment of cells
with pactamycin or T-2 toxin, which results in disintegration of
the active polysomes into 60S and 40S ribosomal subunits and
unprogrammed 80S monosomes; and (ii) inhibition of transla-
tional elongation by pretreatment with emetine, which results
in preserved but inactive polysomes (36).
First we confirmed by sucrose gradient analysis (28) that
treatment of Rat-1 cells with the inhibitors of translational
initiation pactamycin (0.2 mg/ml for 30 min) and T-2 toxin (10
mg/ml for 30 min) resulted in disintegration of the active poly-
somes (data not shown). [3H]leucine incorporation 30 min
after treatment with either pactamycin or T-2 toxin was inhib-
ited by 98% (data not shown). Pactamycin pretreatment com-
pletely abrogated the activation of SAPK/JNK1 by anisomycin
(Fig. 3a; compare lanes 7 to 10 to lanes 12 to 15). In contrast,
following pactamycin pretreatment, the activation of SAPK/
JNK1 by the proinflammatory cytokine interleukin-1a (IL-1a)
was not only preserved but was even prolonged in time (Fig.
3a; compare lanes 17 to 20 to lanes 22 to 25). This indicated
that pactamycin pretreatment did not generally diminish the
responsiveness of SAPK/JNK1 but specifically inhibited the
response to anisomycin. Similarly, pretreatment of cells with
T-2 toxin did not decrease the responsiveness of SAPK/JNK1
to IL-1a (Fig. 3b; compare lanes 5 and 6) but abrogated the
activation of SAPK/JNK1 by anisomycin (Fig. 3b; compare
lanes 3 and 4).
As expected, treatment of cells for various lengths of time
(from 10 min to 2 h) with emetine (100 mg/ml), an inhibitor of
ribosomal translocation, failed to change the polysomal pro-
files in Rat-1 cells (data not shown). However, the observed
polysomes were nonfunctional, as the [3H]leucine incorpora-
tion was inhibited by 98% (data not shown and Fig. 3c, upper
panel). Importantly, emetine at 100 mg/ml completely blocked
translation within 1 min after addition (Fig. 3c, upper panel).
Treatment of cells with emetine for 2 min before addition of
either anisomycin or IL-1a abrogated the responsiveness of
SAPK/JNK1 to anisomycin (Fig. 3c; compare lanes 3 and 4)
but did not diminish the activation of the kinase by IL-1a (Fig.
3c, bottom panel; compare lanes 5 and 6). If emetine was given
2 min after the treatment of cells with either anisomycin or
IL-1a, SAPK/JNK1 responded well to IL-1a but the respon-
siveness of the kinase to anisomycin was restored as well (Fig.
3c, bottom panel; compare lanes 9 and 10 and lanes 11 and 12).
These results indicate that the emetine-sensitive (presumably
ribosomal) step of the anisomycin-induced signal transduction
to SAPK/JNK1 occurs within the first 2 min after addition of
anisomycin. Furthermore, these results suggest that the abro-
gation of anisomycin-induced activation of SAPK/JNK1 by
pretreatment with ribosomal inhibitors probably did not result
from a rapid turnover of a labile protein that participates in the
signal transduction cascade used by anisomycin; if such a labile
protein(s) exists, its level in the cell must decrease significantly
within the first minutes after initiation of the translational
block. On the basis of the ability of the ribosomal inactivators
tested to inhibit the responsiveness of SAPK/JNK1 to aniso-
mycin while not impeding the IL-1a-induced activation of the
kinase, we concluded that the transduction of the anisomycin-
initiated signal to SAPK/JNK1 requires the presence of ribo-
somes actively engaged in translation.
Activation of SAPK/JNK1 by APNAs. The binding site for
anisomycin is located in domain V of the 28S rRNA (21, 39,
45) (Fig. 4a). (The nomenclature of the domains is derived
from that of the Escherichia coli 23S rRNA as in reference 33).
The same region has been proposed to be part of the ribosomal
peptidyl transferase center (for reviews, see references 2 and
39). It is possible, therefore, that binding of anisomycin to its
cognate sequence in the 28S rRNA causes alterations in the
RNA molecule that interfere with the peptidyl transferase
reaction on one hand and serve as a recognition signal for
activation of SAPK/JNK1 on the other hand. In search of
arguments in support of this hypothesis, we noticed that the
same region of the 28S rRNA is also the ribosomal target for
the aminohexose pyrimidine nucleoside antibiotic (APNA)
blasticidin S (39) (Fig. 4a). Like anisomycin, blasticidin S and
other members of the APNA family specifically inhibit the
peptidyl transferase reaction (36, 50) (Fig. 2a). If alterations in
the 28S rRNA, induced by binding of an antibiotic, could
account for both the inhibition of translation and the activation
of SAPK/JNK1, then treatment of cells with APNAs should
also result in SAPK/JNK1 activation. Therefore, we treated
cells with either blasticidin S or gougerotin, a structurally re-
lated APNA, and monitored the activity of SAPK/JNK1. Both
antibiotics (300 mM each) appeared to require inclusion in
lipid vesicles (lipofection; see Materials and Methods) in order
to be efficiently delivered into Rat-1 cells (as measured by
inhibition of translation) (data not shown). Like anisomycin,
both blasticidin S and gougerotin potently induced an early (15
min after addition) and persistent activation of SAPK/JNK1
(Fig. 4b). Furthermore, pretreatment of cells with emetine
FIG. 1. Anisomycin-induced inhibition of translation and activation of
SAPK/JNK1 in Rat-1 cells. Cells were treated with anisomycin at the indicated
concentrations for 15 min and then either pulse-labeled with [3H]leucine for 5
min or harvested for SAPK/JNK1 immunocomplex kinase assays as described in
Materials and Methods. (a) Graphic representation of translational inhibition
and SAPK/JNK1 activity as functions of the concentration of anisomycin. max.,
maximum. (b) SAPK/JNK1 immunocomplex kinase assay using GST-Elk1 fusion
protein as a substrate for phosphorylation. The gel represents the data showed in
panel a. The position of the full-length GST-Elk1 fusion protein (amino acid
residues 307 to 428, representing the transcriptional activation domain of the
human Elk-1 [38]) is marked by an arrow. The intensity of the lower phosphor-
ylated band (marked p) varies in different preparations of GST-Elk1 (compare
panel b with Fig. 4b). Since it is not present in preparations from bacteria
expressing only GST (data not shown), and since its phosphorylation correlates
with the phosphorylation pattern of the full-length GST-Elk1, it most likely
represents a proteolytic fragment of the latter that contains the Elk-1 phosphoac-
ceptor sites and the recognition sequence for the binding of SAPK/JNK1. Co,
control.
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abolished the activation of SAPK/JNK1 by either blasticidin S
or gougerotin (data not shown), just as it did to the activation
of SAPK/JNK1 by anisomycin (Fig. 3c). These findings are
consistent with the notion that inhibitors of the peptidyl trans-
ferase reaction initiate signal transduction to SAPK/JNK1 via
specific binding to a common cognate sequence in the 28S
rRNA.
Activation of SAPK/JNK1 by ricin A chain and a-sarcin. We
next tested the hypothesis that the 28S rRNA is involved in
signaling to SAPK/JNK1 by using an experimental approach
that is independent of the binding of antibiotic inhibitors of
translation and that is based on two highly specific enzymatic
reactions. The ribotoxic enzymes ricin A chain and a-sarcin
specifically damage the S/R loop in the 28S rRNA (Fig. 4a).
This fact enabled us to test experimentally whether RNA dam-
age and/or conformational changes in the 28S rRNA may con-
stitute an initiation event for a signal transduction to SAPKs/
JNKs. Ricin A chain is an RNA N-glycosidase that depurinates
a single adenosine at position A4324 of the 28S rRNA (see
reference 52 and references therein) (Fig. 4a). The natural
source of ricin A chain is the lectin RCA60 from the castor
plant Ricinus communis. RCA60 is a dimer of the ricin A and
B chains, the latter being required for the delivery of the active
(ribotoxic) A chain to the cell interior (for a review, see ref-
erence 35). Therefore, RCA60 was used to deliver the toxin
into Rat-1 cells. First, we developed an experimental assay to
monitor the in vivo ricin A chain-induced depurination of
A4324 based on lesion-induced arrest of a reverse transcrip-
tase-driven primer extension (see Materials and Methods).
The reverse transcription on ricin A chain-damaged 28S rRNA
terminates abruptly at position G4323, which is located 59 of
the depurinated A4324. Treatment of cells with RCA60 re-
sulted in substantial and precise damage to A4324 (Fig. 5;
compare lane 6 to lanes 7 to 11) and potently inhibited protein
synthesis as measured by [3H]leucine incorporation (Fig. 6a).
The specificity of the ricin A chain-induced lesion to A4324
was confirmed by using six primers that hybridize to different
regions of the 28S rRNA; they failed to detect any other site of
damage (data not shown). Consistent with our hypothesis, the
ricin A chain strongly activated SAPK/JNK1 (Fig. 6b; Fig. 6c,
lanes 2 to 5). This activation was contemporaneous with the
ricin A chain-induced phosphorylation at threonine 223 of
SEK1/MKK4 (Fig. 6d, lanes 2 to 5), a marker for MKK4/SEK1
activation (55). The depurination of A4324 became apparent
15 min after the RCA60 treatment and reached a maximum at
30 min posttreatment (Fig. 6e, upper panel). Both the phos-
phorylation of SEK1/MKK4 and the activation of SAPK/JNK1
were observed at 30 min but not at 15 min (Fig. 6e, middle and
lower panels, respectively).
a-Sarcin is an RNA endonuclease from Aspergillus giganteus
that in intact ribosomes selectively cleaves the phosphodiester
bond on the 39 side of position G4325, adjacent to the A4324
that is depurinated by the ricin A chain (see reference 52 and
references therein) (Fig. 4a). The delivery of a-sarcin into
Rat-1 cells required its inclusion in lipid vesicles (lipofection;
see Materials and Methods). Lipofected a-sarcin proved to be
an effective inhibitor of protein synthesis (Fig. 6a) and acti-
vated both SEK1/MKK4 (Fig. 6d, lanes 7 to 10) and SAPK/
JNK1 (Fig. 6b; and Fig. 6c, lanes 8 to 11). Neither ricin A chain
nor a-sarcin appeared to activate the extracellular signal-reg-
ulated kinase ERK1 (data not shown).
Based on the structural and the functional homologies be-
tween the E. coli 23S rRNA and the eukaryotic 28S rRNA, it
is believed that elongation factor 2 (EF-2)-dependent ribo-
somal translocation is mediated by the binding of EF-2 to the
FIG. 2. Inhibition of translation and activation of SAPK/JNK1 by antibiotic
inhibitors of translation. (a) A schematic presentation of the ribosomal cycle (for
a review, see reference 32) and action of antibiotic inhibitors of translation and
ribotoxic enzymes. Only initiation and elongation are presented; termination of
translation is not shown. Pactamycin binds to the 16S rRNA (15) and prevents
the binding of the initiator tRNA1Met (Met-tRNAn51) to the small ribosomal
subunit during the formation of the initiation complex; therefore, it is a potent
inhibitor of translational initiation (36). T-2 toxin inhibits the peptidyl trans-
ferase reaction of eukaryotic ribosomes only in the formation of the first, post-
initiational methionyl-aminoacyl peptide bond (44) and therefore acts as an
inhibitor of translational initiation. Anisomycin and the APNAs block the pep-
tidyl transfer at each translational step (36). Puromycin resembles the aminoacyl-
adenylyl end of the aminoacyl-tRNA (AA-tRNAn52) in the A site. It thereby
prematurely terminates the elongation of the polypeptide chain by competing
with the aminoacyl-tRNA for the peptidyl transfer (36). Cycloheximide inhibits
translation by preventing the release of the deacylated tRNA after the peptidyl
transferase reaction has taken place, thus abrogating the translocation of the
peptidyl-tRNA from the A to the P site (36). 80S ribosomes treated with emetine
are deficient in translocation (36, 50). The modes of action of the ribotoxic
enzymes used are explained in the text. (b) Cells were treated in triplicate for 10
min with anisomycin (10 mg/ml), cycloheximide (CHX; 25 mg/ml), puromycin (75
mg/ml), pactamycin (0.2 mg/ml), emetine (10 mg/ml), or T-2 toxin (10 mg/ml) and
then pulse-labeled with [3H]leucine for another 5 min. Co, control; SD, standard
deviation. (c) Cells were treated for 15, 30, 60, or 90 min with each of the
antibiotics used in the experiment shown in panel b and at identical concentra-
tions. Cells were then harvested and processed for SAPK/JNK1 immunocomplex
kinase assays as described for Fig. 1b. Quantitative representation is shown,
obtained from PhosphorImager analysis.
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S/R loop (53), similar to the binding of EF-G, the E. coli
homolog of EF-2, to the same loop in the 23S rRNA (31). The
ribotoxic enzyme from Corynebacterium diphtheriae (diphtheria
toxin) and exotoxin A from Pseudomonas aeruginosa inactivate
EF-2 by causing its specific ADP-ribosylation (for a review, see
reference 35). The ADP-ribosylated EF-2 loses its affinity for
the pretranslocational ribosome and cannot catalyze the ribo-
somal translocation, thus leading to cessation of translation
(43) (Fig. 2a). As the ADP-ribosylation of EF-2 interferes with
the function of the S/R loop without causing RNA damage, we
asked whether treatment of Rat-1 cells with diphtheria toxin
and Pseudomonas exotoxin A could also activate SAPK/JNK1.
Because mouse and rat cells lack functional diphtheria toxin
receptors (30), we delivered the toxin into Rat-1 cells via lipo-
fection, which effectively inhibited protein synthesis (Fig. 6a).
Pseudomonas exotoxin A inhibited translation without requir-
ing a vehicle for delivery (Fig. 6a). These two toxins differed
significantly from ricin A chain and a-sarcin in their ability to
activate SAPK/JNK1; Pseudomonas exotoxin A completely
failed to activate the kinase (Fig. 6b; Fig. 6c, lanes 13 to 16),
and diphtheria toxin reproducibly caused a detectable but only
marginal activation (Fig. 6b; Fig. 6c, lanes 19 to 22; Fig. 7c,
lanes 3 and 8). The ability of ricin A chain and a-sarcin, but not
of diphtheria toxin and Pseudomonas exotoxin A, to strongly
activate SAPK/JNK1 is consistent with our hypothesis that
RNA damage to the S/R loop initiates signal transduction to
SAPK/JNK1.
Ricin A chain and a-sarcin require functional ribosomes in
order to activate SAPK/JNK1. If ricin A chain and a-sarcin
activate SAPK/JNK1 through pathways similar to that of ani-
somycin, it would be expected that both ribotoxins would also
require active ribosomes for the activation. Just as with aniso-
mycin, in Rat-1 cells pretreated with pactamycin, the activation
of SAPK/JNK1 by both ricin A chain and a-sarcin was severely
reduced (Fig. 7a; compare lanes 4 and 5 and lanes 6 and 7).
Furthermore, cells arrested in their elongation cycle by pre-
treatment with emetine were also unable to activate SAPK/
JNK1 in response to ricin A chain and were significantly ham-
pered in their ability to respond to a-sarcin (Fig. 7b; compare
lanes 3 and 4 and lanes 7 and 8). A possible explanation for the
ability of pactamycin and emetine to interfere with the ricin A
chain- and a-sarcin-induced SAPK/JNK1 activation is that the
inactivated ribosomes were not susceptible to RNA damage by
ricin A chain or a-sarcin. The validity of this explanation was
tested by exposing cells to either pactamycin or emetine prior
to exposure to ricin A chain. As shown in Fig. 5, lanes 12 to 15,
pretreatment of cells with pactamycin or emetine failed to
inhibit the ricin A chain-induced A4324 depurination.
Consistent with the results obtained with pactamycin or em-
etine, in cells pretreated with diphtheria toxin, neither ricin A
chain nor a-sarcin was able to activate SAPK/JNK1 substan-
tially above the low level of activation induced by diphtheria
toxin alone (Fig. 7c; compare lanes 3 to 5 and lanes 8 to 10),
confirming that active ribosomes are required for the activa-
tion of SAPK/JNK1 by the two ribotoxins.
Activation of c-fos and c-jun expression by damage to the S/R
loop. Potentiation of MAPK by anisomycin activates the tran-
scription of the immediate-early genes c-fos and c-jun (56).
FIG. 3. Inhibition of the anisomycin-induced activation of SAPK/JNK1 by pretreatment of Rat-1 cells with pactamycin, T-2 toxin, or emetine. (a) Cells were left
untreated or were pretreated, as indicated at the left side of each panel, with pactamycin (0.2 mg/ml) for 30 min and then stimulated as indicated with anisomycin (10
mg/ml) or IL-1a (25 ng/ml) for 15, 30, 60, or 90 min. The upper panel represents the effect of pactamycin alone on the activity of SAPK/JNK1 at all time points used
in the lower panels. (Note that in Fig. 3a and 6c, some of the control lanes [Co] have been presented more than once for easier comparison. Each control lane, however,
is matched to its properly corresponding experimental lanes.) (b) Cells were left untreated or were pretreated as indicated with T-2 toxin (T2; 10 mg/ml) for 30 min.
Cells were then stimulated as indicated with either anisomycin (Aniso) or IL-1a at the concentrations used for the experiment shown in panel a for 15 min. (c) Upper
panel: cells (in triplicate) were left untreated (control) or were treated with emetine (100 mg/ml) and then immediately exposed to a pulse of [3H]leucine for 1, 2, 3,
4, or 5 min. SD, standard deviation. Lower panel: cells were treated as indicated with anisomycin (Aniso) or IL-1a as described for panel b. Emetine (100 mg/ml) was
given as indicated either 2 min before [Em (229)] or 2 min after [Em (129)] the respective agonist. Just as with GST-Elk1 (see the legend to Fig. 1b), GST-cJun
preparations display a second phosphorylated band (p) which most likely represents a proteolytic fragment containing the SAPK/JNK1 recognition sequence and the
phosphoacceptor sites (serines 63 and 73 [19]) of cJun.
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When added in combination with activating growth factors,
anisomycin augments and prolongs the accumulation of imme-
diate-early gene mRNA, a phenomenon known as superinduc-
tion (14, 29). We tested whether RNA damage in the S/R loop,
together with epidermal growth factor (EGF), could induce
and superinduce the expression of c-fos and c-jun mRNA.
Northern blot analyses in Rat-1 cells showed that the ricin A
chain induced the accumulation of c-fos and c-jun mRNA
when applied alone (Fig. 8, lanes 2 to 6) and strongly super-
induced their accumulation when applied together with EGF
(Fig. 8; compare lanes 7 to 9 with lanes 10 to 12).
DISCUSSION
Inhibition of protein synthesis per se does not activate
SAPK/JNK1. Using eight antibiotic ribosomal inhibitors and
four ribotoxic enzymes, we have demonstrated that at concen-
trations sufficient to impair [3H]leucine incorporation by more
than 90%, the inhibitors of translation differ significantly in
their ability to activate SAPK/JNK1 (Fig. 2, 6, and 7) and that
inhibition of protein synthesis per se cannot account for the
SAPK/JNK1 activation. Recently, similar results demonstrat-
ing that anisomycin, but not cycloheximide and emetine, is a
potent inducer of SAPK/JNK1 and SAPK/JNK2 activities in
NIH 3T3 cells were reported (42). Therefore, the mechanisms
by which some translational inhibitors activate SAPK/JNK1
are likely to be understood on the basis of the molecular
alterations these agents cause in the ribosome. In an attempt to
characterize one such mechanism, we concentrated on the
binding of anisomycin to the 28S rRNA and on the 28S rRNA-
damaging capacity of the ribotoxins ricin A chain and a-sarcin.
The 28S rRNA as a sensor for ribotoxic stress. Is there
evidence to support the notion that the 28S rRNA is the sensor
for anisomycin-induced ribotoxic stress and is implicated in the
activation of SEK1/MKK4 and SAPK/JNK1 by anisomycin?
We made use of APNAs, which, like anisomycin, inhibit the
peptidyl transferase reaction (36 and 50) (Fig. 2a) and bind to
the same region of domain V of 28S rRNA (39) (Fig. 4a).
Blasticidin S and gougerotin, members of the APNA family,
caused SEK1/MKK4 phosphorylation (data not shown) and
activation of SAPK/JNK1 (Fig. 4b) as potently as anisomycin.
Anisomycin and APNAs, although structurally dissimilar, bind
to the same region of the 28S rRNA. Both require functional
ribosomes to activate SAPK/JNK1 (Fig. 3 and data not shown).
Therefore, it appears likely that the signal for activation of
SAPK/JNK1 in response to either anisomycin or APNAs orig-
inates in their shared binding site in the ribosome.
The most convincing support for the hypothesis that the 28S
rRNA serves as a sensor for ribotoxic stress came from exper-
iments showing that nucleotide-specific RNA damage to the
FIG. 4. (a) Secondary structure of the region of the 28S rRNA targeted by
anisomycin (domain V) and by the ribotoxin enzymes ricin A chain and a-sarcin
(domain VI) as presented in reference 53, with modifications reflecting recent
data on the conformation of the S/R loop (46). Watson-Crick pairing is denoted
by black dots; non-Watson-Crick pairing is denoted by black squares. Within the
large shaded square is contained the portion of rRNA considered to be the site
of action of anisomycin. The nucleotides subject to substitutions in the anisomy-
cin-resistant mutants of Tetrahymena 28S rRNA and Halobacterium 23S rRNA
(21, 45) are denoted by open squares. Open circles represent conserved nucleo-
tides protected by anisomycin from chemical modifications in vitro (39). (b) Ac-
tivation of SAPK/JNK1 by the APNAs gougerotin and blasticidin S. Rat-1 cells
were treated with the antibiotics (300 mM each) for the indicated periods of time,
and SAPK/JNK1 activity was assayed essentially as described in the legend to Fig. 2c
except that the antibiotics were delivered via lipofection (see Materials and
Methods). The asterisk indicates the same thing as in Fig. 1b. Co, control;
DMSO, dimethyl sulfoxide.
FIG. 5. Detection of ricin A chain-induced depurination of A4324 in vivo via
reverse transcription of 28S rRNA. Rat-1 cells were left untreated or were
treated with RCA60 (10 mg/ml) for the indicated periods of time. Lanes 6 to 11,
cells were treated with RCA60 for up to 3 h; lanes 12 to 15, cells were either
treated with RCA60 alone for 30 min or were pretreated with pactamycin (0.2
mg/ml) or emetine (10 mg/ml) for 30 min prior to exposure to RCA60 (as
indicated). Total RNA was prepared and reverse transcriptase-driven primer
extension was performed as described in Materials and Methods. The reverse
transcriptase stop site is indicated by an arrow, and its exact position was deter-
mined via reverse transcriptase-mediated RNA sequencing (see Materials and
Methods), shown in lanes 1 to 4 (dotted line). (The sequencing reactions G, A,
T, and C (copy ribosomal DNA) are indicated as C, U, A, and G, respectively,
to reflect the complementary rRNA sequence.) The sequence of the S/R loop is
shown on the left side of the figure.
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S/R loop of the 28S rRNA, induced by the ribotoxic enzymes
ricin A chain and a-sarcin, initiates a cellular response that
involves phosphorylation of SEK1/MKK4, activation of SAPK/
JNK1, and transcriptional induction of immediate-early genes
such as c-fos and c-jun (Fig. 6 and 8). This response resembles
the cellular reaction to anisomycin, as ribosomes that had been
subjected to prior inactivation were unable to mediate the
activation of SAPK/JNK1 in response to ricin A chain and
a-sarcin (Fig. 7).
What are the intermediate signal transduction steps be-
tween the damage to 28S rRNA and activation of the SEK1/
MKK4-SAPK/JNK1 cascade? Since cells containing transla-
tionally inactivated ribosomes fail to activate SAPK/JNK1 in
response to anisomycin, ricin A chain, a-sarcin (Fig. 3 and 7),
or APNAs (data not shown), it is possible that active ribosomes
provide not only the sensor for ribotoxic stress but also the
transduction machinery that translates the alterations in the
28S rRNA into a signal recognized by cellular components that
lie upstream of SEK1/MKK4 and SAPK/JNK1. Although these
intermediates remain unidentified, our data provide insight
into some of their properties. For instance, pretreatment of
Rat-1 cells with pactamycin or emetine did not prevent the 28S
rRNA damage caused by ricin A chain but completely abro-
gated the activation of SAPK/JNK1 (Fig. 5 and 7a and b).
Therefore, we conclude that ribosomes arrested in the pre-
translocational state (e.g., by emetine pretreatment) or disin-
tegrated into free subunits and unprogrammed monosomes by
inhibitors of translational initiation (e.g., by pactamycin pre-
treatment) have lost their ability to transduce the signal from
the 28S rRNA to SEK1/MKK4. This suggests that the binding
of a signal-transducing molecule (such as a protein) may be
restricted to a certain stage of the ribosomal cycle and that the
binding of this transducing component may be abolished in
arrested ribosomes. Examples of proteins that bind to the S/R
loop in a ribosomal cycle-dependent manner are the elonga-
tion factors EF-Tu/EF-1 and EF-G/EF-2 (31, 32, 53). ADP-
ribosylation of EF-2 inhibited the activation of SAPK/JNK1 by
ricin A chain or a-sarcin (Fig. 7c). This inhibition may result
from either (i) the arrest of the ribosomal cycle caused by
ADP-ribosylation of EF-2 and subsequent prevention of the
binding of a transducer protein different from EF-2 or (ii)
inhibition of the binding of EF-2, which may itself be the
transducer. Our experiments do not let us distinguish between
these possibilities.
Once initiated, the signal from the damaged and/or confor-
mationally altered 28S rRNA rapidly stimulates the pathway(s)
leading to activation of SAPK/JNK1. SEK1/MKK4 became
phosphorylated following treatment with anisomycin and
APNAs (22) and after addition of ricin A chain or a-sarcin
(Fig. 3 and 6d). SEK1/MKK4 becomes phosphorylated follow-
ing IL-1a stimulation of Rat-1 cells as well (22). These data
indicate that ribotoxic stress and growth factor- or cytokine
receptor-activated signal transduction cascades leading to po-
tentiation of SAPKs/JNKs have at least one common compo-
nent upstream of SAPK/JNK1, i.e., SEK1/MKK4.
Evolutionary conservation of the stress-sensoring functions
of ribosomes. Although to our knowledge this is the first report
that describes the ability of eukaryotic ribosomes to sense
FIG. 6. Inhibition of translation, phosphorylation of SEK1/MKK4, and activation of SAPK/JNK1 by ribotoxic enzymes in Rat-1 cells. (a) Cells were treated in
triplicate with Pseudomonas exotoxin A (5 mg/ml) without lipofection, or with diphtheria toxin (20 mg/ml) or a-sarcin (20 mg/ml) via lipofection (p), as described in
Materials and Methods, and the levels of [3H]leucine incorporation were determined 4 h after treatment. Appropriate control cells received lipofection mix without
toxins, and the inhibition of protein synthesis by diphtheria toxin or a-sarcin was determined relative to these control cells. Error bars denote the standard deviations
(SD) of independent dishes in triplicate. (b and c) Cells were left untreated or were treated with Pseudomonas exotoxin A, diphtheria toxin, RCA60, a-sarcin, or (when
required) lipofectin alone as for panel a for 0.5, 1, 2, or 4 h and were then harvested for determination of SAPK/JNK1 activity with GST-Elk1. The quantitative
representation of the results shown in panel c is presented in panel b. Here, SAPK/JNK1 activity after lipofection alone is shown only for the 4-h time point (lanes 7
and 18), but see also Fig. 4b, lanes 2 to 5, for 15, 30, 60 and 90 min. (d) Cells were treated as described for panels b and c, and the phosphorylation of SEK1/MKK4
at threonine 223 was detected in a Western blot analysis as described in Materials and Methods. LF, lipofectin. (e) Cells were left untreated or were treated with RCA60
(10 mg/ml) for 5, 10, 15, 30, or 60 min. The depurination of A4324, the phosphorylation of SEK1/MKK4, and the activation of SAPK/JNK1 (using GST-Elk1) were
determined from separate tissue culture dishes as described in Materials and Methods. Co, control.
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cellular stress and to initiate cellular stress responses, similar
functions for prokaryotic ribosomes have previously been re-
ported. For example, prokaryotic ribosomes produce guano-
sine 39,59-bispyrophosphate (ppGpp) in response to stalling
caused by amino acid starvation (5). The production of ppGpp
results in abrupt transcriptional inhibition of genes encoding
components of the translational apparatus (5). Another exam-
ple of ribosome-mediated stress signaling is the selective up-
regulation of the expression of stress proteins in response to
antibiotic-induced inhibition of overall protein synthesis in
E. coli (48). Interestingly, similar to the results from Rat-1 cells
presented here, E. coli does not mount a general stress reac-
tion to all translational inhibitors. Instead, the response is
antibiotic specific. Chloramphenicol, erythromycin, fusidic
acid, tetracycline, and spiramycin all induce cellular reactions
indistinguishable from the bacterial cold shock response,
whereas kanamycin, puromycin, and streptomycin induce the
expression of the full complement of proteins characterizing
the bacterial heat shock response (48). Our results demon-
strate that the ribotoxic stress response in Rat-1 cells was
blocked by pretreatment with some translational inhibitors.
Similarly, pretreatment of E. coli with tetracycline, which pro-
duces a cold shock response, blocks the cellular response to
subsequent heat shock (48). Interestingly, chloramphenicol
and erythromycin (inducers of the cold shock response) bind to
the same region of the 23S rRNA in prokaryotes as that to
which anisomycin binds in the 28S rRNA of eukaryotic cells
(Fig. 4a) (10, 39). This striking similarity in the ability of con-
served regions of the 23S and 28S rRNAs to initiate cellular
reactions in response to binding of inhibitors of the peptidyl
transferase reaction in bacteria and in higher eukaryotes sug-
gests the existence of a universal and evolutionarily conserved
function of the ribosome in both sensing stress and directing
the subsequent cellular responses.
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